Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 2
1(50.0%)
N/A
1(50.0%)
2Total
Phase 2(1)
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05326607Not ApplicableCompleted

Pilot Clinical Investigation of Adaptative Eyeglasses for the Correction of Presbyopia

Role: collaborator

NCT04803240Completed

Survey: Evaluation of Ocular Surface Disease Symptoms and Patient Satisfaction With Thealoz® Duo After 84 Days of Daily Treatment

Role: collaborator

NCT03009799Phase 2Withdrawn

Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)

Role: collaborator

NCT01552174Completed

Management of Eyelid Disorders by Ophthalmologists in Usual Medical Practice

Role: collaborator

All 4 trials loaded